Bionano Announces Hiring of Chief Scientific Officer
SAN DIEGO, June 24, 2026 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ: BNGO), a leader in genome analysis solutions, today announced the appointment of Alex Hastie, Ph.D., as...
News Desk
Staff Writer
Published
Jun 25, 2026
Source
The Manila Times
Analytics
0 0 0

AI Insight:Bionano's new Chief Scientific Officer brings expertise to drive innovation in genome analysis.
Bionano Genomics, Inc., a pioneer in genome analysis solutions, has made a significant move in its leadership team by appointing Alex Hastie, Ph.D., as its new Chief Scientific Officer. As a seasoned expert in the field, Dr. Hastie's appointment is expected to propel Bionano's research and development efforts, fostering groundbreaking discoveries in genome analysis. With his extensive experience in leading scientific teams and driving innovation, Dr. Hastie is well-positioned to leverage Bionano's cutting-edge technologies to advance the field of genomics. This strategic hire underscores Bionano's commitment to staying at the forefront of genome analysis solutions, and its dedication to delivering cutting-edge tools to the scientific community.